{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:03:03Z","timestamp":1790845383861,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004686","name":"Deanship of Scientific Research, King Faisal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.lfs.2020.117627","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T20:26:44Z","timestamp":1585945604000},"page":"117627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":303,"special_numbering":"C","title":["Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease"],"prefix":"10.1016","volume":"251","author":[{"given":"Mahmoud","family":"Kandeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Nazawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117627_bb0005","first-page":"1","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.lfs.2020.117627_bb0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117627_bb0015","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/JVI.80.9.4211-4219.2006","article-title":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117627_bb0020","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117627_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid1002.030351","article-title":"Introduction of SARS in France, March\u2013April, 2003","volume":"10","author":"Desenclos","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2020.117627_bb0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ajcp\/aqaa029","article-title":"Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19","volume":"153","author":"Guarner","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.lfs.2020.117627_bb0035","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117627_bb0040","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2020.117627_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1570180815666180918161922","article-title":"Molecular dynamics and inhibition of MERS CoV papain-like protease by small molecule imidazole and aminopurine derivatives","volume":"16","author":"Kandeel","year":"2019","journal-title":"Lett. Drug Des. Discov."},{"issue":"5","key":"10.1016\/j.lfs.2020.117627_bb0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eng.2018.11.035","article-title":"Molecular characteristics, functions, and related pathogenicity of MERS-CoV proteins","volume":"5","author":"Li","year":"2019","journal-title":"Engineering"},{"key":"10.1016\/j.lfs.2020.117627_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.01.015","article-title":"Recent discovery and development of inhibitors targeting coronaviruses","author":"Pillaiyar","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2020.117627_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2020.117627_bb0065","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2020.117627_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/07391102.2015.1014423","article-title":"Molecular analysis of some camel cytochrome P450 enzymes reveals lower evolution and drug-binding properties","volume":"34","author":"Altaher","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2020.117627_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3923\/ijp.2015.243.247","article-title":"Annotation of camel genome for estimation of drug binding power, evolution and adaption of cytochrome P450 1a2","volume":"11","author":"Altaher","year":"2015","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117627_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0031182008005301","article-title":"Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery","volume":"136","author":"Kandeel","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.lfs.2020.117627_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2012.07.009","article-title":"In silico virtual screening approaches for anti-viral drug discovery","volume":"9","author":"Murgueitio","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.lfs.2020.117627_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113806","article-title":"Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design","volume":"277","author":"Sheikh","year":"2020","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.lfs.2020.117627_bb0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jcc.20186","article-title":"SARS-CoV protease inhibitors design using virtual screening method from natural products libraries","volume":"26","author":"Liu","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2020.117627_bb0100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/ci034270n","article-title":"Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points","volume":"44","author":"Sirois","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.lfs.2020.117627_bb0105","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2105-13-S17-S5","article-title":"Multiple virtual screening approaches for finding new Hepatitis c virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors","author":"ElHefnawi","year":"2012","journal-title":"BMC Bioinf. BioMed Central"},{"key":"10.1016\/j.lfs.2020.117627_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of small\u2212 molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.lfs.2020.117627_bb0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12539-015-0109-8","article-title":"Flavonoids as multi-target inhibitors for proteins associated with Ebola virus: in silico discovery using virtual screening and molecular docking studies","volume":"8","author":"Raj","year":"2016","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"10.1016\/j.lfs.2020.117627_bb0120","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.117627_bb0125","first-page":"1289","article-title":"Ribavirin in the treatment of SARS: a new trick for an old drug?","volume":"168","author":"Koren","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.lfs.2020.117627_bb0130","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2165\/11204330-000000000-00000","article-title":"Telbivudine","volume":"70","author":"McKeage","year":"2010","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.lfs.2020.117627_bb9000","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2020.117627_bb8000","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520303751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520303751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:03:03Z","timestamp":1762210983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520303751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"alternative-id":["S0024320520303751"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117627","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117627"}}